Summary Keywords GLP-1, Alzheimers disease, Parkinsons disease, neuroinflammation, amyloid beta, mitochondrial dysfunction, brain glucose hypometabolism, insulin resistance Citation Reich N and Hlscher C (2022) The neuroprotective effects of glucagon-like peptide 1 in Alzheimers and Parkinsons disease: An in-depth review
This characteristic has potential application value in the treatment of autoimmune diseases and chronic inflammation
Recently, Semaglutide has been approved by the FDA for weight loss in obese and certain overweight patients
When your gut bacteria break down sulfur-rich vegetables, they release these gasses
Fever: A fever (e.g., 38.1C or higher) alongside nausea could be a sign of an infection or other medical condition that needs to be addressed